Novuson | Stuart Mitchell, Founder & CEO

Novuson’s patented DTU technology will represent the first substantive innovation in over 25 years for targeting vessel sealing / dividing, and hemostasis (bleeding control) in surgical and trauma applications.
Speakers
Stuart Mitchell
Stuart Mitchell
Founder/CEO, Novuson